Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex.
In this report, we study the drugs for pruritus.
This report contains market size and forecasts of Pruritus Therapeutics in Global, including the following market information:
Global Pruritus Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pruritus Therapeutics market was valued at 14080 million in 2021 and is projected to reach US$ 18310 million by 2028, at a CAGR of 3.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antihistamines Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pruritus Therapeutics include J&J, Abbott, Amgen, LEO Pharma, Novartis, Bayer, Pfizer, UCB Pharma and GlaxoSmithKline, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pruritus Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pruritus Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pruritus Therapeutics Market Segment Percentages, by Type, 2021 (%)
Antihistamines
Corticosteroids
Calcineurin Inhibitors
Others
Global Pruritus Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Pruritus Therapeutics Market Segment Percentages, by Application, 2021 (%)
External Use
Oral
Injection
Global Pruritus Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Pruritus Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pruritus Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Pruritus Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
J&J
Abbott
Amgen
LEO Pharma
Novartis
Bayer
Pfizer
UCB Pharma
GlaxoSmithKline
Galderma
Huapont

LEAVE A REPLY

Please enter your comment!
Please enter your name here